Samjo Capital’s Novo Nordisk NVO Stock Holding History

Samjo Capital’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$509K	Buy	+5,600	New	+$493K	0.2%	32

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Samjo Capital's NVO Position: Q3 2023 in Review

Samjo Capital opened a new position in Novo Nordisk (NVO) in Q3 2023: 5,600 shares worth $509K. The stake represents 0.2% of the portfolio and ranks #32 among its holdings.

1,307 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

Samjo Capital held 5,600 shares of Novo Nordisk worth $509K as of Q3 2023.
Novo Nordisk was a new Samjo Capital position in Q3 2023.
Novo Nordisk made up 0.2% of Samjo Capital's portfolio in Q3 2023, its #32 holding.
1,307 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on Samjo Capital's 13F filing for Q3 2023, filed 14 Nov 2023.